FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4280498084> ?p ?o ?g. }

• W4280498084 endingPage "15" @default.
• W4280498084 startingPage "8" @default.
• W4280498084 abstract "Active surveillance (AS) of biopsy-proven renal oncocytomas may reduce overtreatment. However, on biopsy, the risk of misdiagnosis owing principally to entities with peculiar hybrids and overlap morphology, and phenotypes argues for early intervention. To assess the benefit and harm of AS in biopsy-proven renal oncocytoma. A systematic review was conducted according to the Preferred Reporting Items for Systematic Reviews and Meta-analyses (PRISMA). We systematically searched PubMed, Scopus, and Web of Science databases from September 26 up to October 2021, for studies that analyzed the outcomes of AS in patients with biopsy-proven renal oncocytoma. A total of ten studies with 633 patients met our inclusion criteria and were included for analysis. After a median follow-up of 34.5 mo (95% confidence interval [CI] 30.6–38.4), the overall definitive treatment rate from AS to definitive treatment was 17.3% (n = 75/433, six studies). The pooled pathological agreement between the initial renal mass biopsy and the surgical pathology report was 91.1%. The main indications for surgery during follow-up were rapid tumor growth and patient request. The pooled median growth rate was 1.55 mm/yr (95% CI 0.9–2.2). No metastasis or death related to renal oncocytoma was reported. Annual tumor growth of biopsy-proven renal oncocytoma is low. AS is oncologically safe, with favorable compliance of patients. Crossover to definitive treatment revealed a strong concordance between biopsy and final pathology. Further studies on the long-term outcomes of AS are needed. In this study, we examined the benefit and harm of active surveillance (AS) in biopsy-proven oncocytoma. Based on the available data, AS appears oncologically safe and may represent a promising alternative to immediate treatment. Patients should be included in AS decision discussions." @default.
• W4280498084 created "2022-05-22" @default.
• W4280498084 creator A5001576637 @default.
• W4280498084 creator A5002369232 @default.
• W4280498084 creator A5007332570 @default.
• W4280498084 creator A5014795561 @default.
• W4280498084 creator A5017594953 @default.
• W4280498084 creator A5030863027 @default.
• W4280498084 creator A5033684101 @default.
• W4280498084 creator A5038866794 @default.
• W4280498084 creator A5040135382 @default.
• W4280498084 creator A5043690288 @default.
• W4280498084 creator A5063195568 @default.
• W4280498084 creator A5068958718 @default.
• W4280498084 creator A5075299562 @default.
• W4280498084 creator A5079401169 @default.
• W4280498084 date "2022-07-01" @default.
• W4280498084 modified "2023-10-01" @default.
• W4280498084 title "Benefit and Harm of Active Surveillance for Biopsy-proven Renal Oncocytoma: A Systematic Review and Pooled Analysis" @default.
• W4280498084 cites W1588502683 @default.
• W4280498084 cites W1924981906 @default.
• W4280498084 cites W1955938072 @default.
• W4280498084 cites W1999321466 @default.
• W4280498084 cites W2034579655 @default.
• W4280498084 cites W2040228974 @default.
• W4280498084 cites W2084587052 @default.
• W4280498084 cites W2143010481 @default.
• W4280498084 cites W2160046662 @default.
• W4280498084 cites W2264210466 @default.
• W4280498084 cites W2284518822 @default.
• W4280498084 cites W2317676294 @default.
• W4280498084 cites W2341822128 @default.
• W4280498084 cites W2502607946 @default.
• W4280498084 cites W2531269403 @default.
• W4280498084 cites W2568792929 @default.
• W4280498084 cites W2760553304 @default.
• W4280498084 cites W2763119021 @default.
• W4280498084 cites W2792702826 @default.
• W4280498084 cites W2797423083 @default.
• W4280498084 cites W2902590347 @default.
• W4280498084 cites W2962782933 @default.
• W4280498084 cites W2963129781 @default.
• W4280498084 cites W2982330933 @default.
• W4280498084 cites W3034045959 @default.
• W4280498084 cites W3036118423 @default.
• W4280498084 cites W3046838284 @default.
• W4280498084 cites W3118615836 @default.
• W4280498084 cites W3165554845 @default.
• W4280498084 cites W3165786888 @default.
• W4280498084 doi "https://doi.org/10.1016/j.euros.2022.04.009" @default.
• W4280498084 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35633831" @default.
• W4280498084 hasPublicationYear "2022" @default.
• W4280498084 type Work @default.
• W4280498084 citedByCount "5" @default.
• W4280498084 countsByYear W42804980842022 @default.
• W4280498084 countsByYear W42804980842023 @default.
• W4280498084 crossrefType "journal-article" @default.
• W4280498084 hasAuthorship W4280498084A5001576637 @default.
• W4280498084 hasAuthorship W4280498084A5002369232 @default.
• W4280498084 hasAuthorship W4280498084A5007332570 @default.
• W4280498084 hasAuthorship W4280498084A5014795561 @default.
• W4280498084 hasAuthorship W4280498084A5017594953 @default.
• W4280498084 hasAuthorship W4280498084A5030863027 @default.
• W4280498084 hasAuthorship W4280498084A5033684101 @default.
• W4280498084 hasAuthorship W4280498084A5038866794 @default.
• W4280498084 hasAuthorship W4280498084A5040135382 @default.
• W4280498084 hasAuthorship W4280498084A5043690288 @default.
• W4280498084 hasAuthorship W4280498084A5063195568 @default.
• W4280498084 hasAuthorship W4280498084A5068958718 @default.
• W4280498084 hasAuthorship W4280498084A5075299562 @default.
• W4280498084 hasAuthorship W4280498084A5079401169 @default.
• W4280498084 hasBestOaLocation W42804980841 @default.
• W4280498084 hasConcept C126322002 @default.
• W4280498084 hasConcept C126838900 @default.
• W4280498084 hasConcept C160798450 @default.
• W4280498084 hasConcept C17744445 @default.
• W4280498084 hasConcept C189708586 @default.
• W4280498084 hasConcept C199539241 @default.
• W4280498084 hasConcept C2775934546 @default.
• W4280498084 hasConcept C2777430276 @default.
• W4280498084 hasConcept C2779473830 @default.
• W4280498084 hasConcept C2780091579 @default.
• W4280498084 hasConcept C2780674462 @default.
• W4280498084 hasConcept C2781087799 @default.
• W4280498084 hasConcept C71924100 @default.
• W4280498084 hasConcept C95190672 @default.
• W4280498084 hasConceptScore W4280498084C126322002 @default.
• W4280498084 hasConceptScore W4280498084C126838900 @default.
• W4280498084 hasConceptScore W4280498084C160798450 @default.
• W4280498084 hasConceptScore W4280498084C17744445 @default.
• W4280498084 hasConceptScore W4280498084C189708586 @default.
• W4280498084 hasConceptScore W4280498084C199539241 @default.
• W4280498084 hasConceptScore W4280498084C2775934546 @default.
• W4280498084 hasConceptScore W4280498084C2777430276 @default.
• W4280498084 hasConceptScore W4280498084C2779473830 @default.
• W4280498084 hasConceptScore W4280498084C2780091579 @default.
• W4280498084 hasConceptScore W4280498084C2780674462 @default.
• W4280498084 hasConceptScore W4280498084C2781087799 @default.

• next